Acadian Asset Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Buy
5,277,904
+861,001
+19% +$1.35M ﹤0.01% 1001
2025
Q4
$13.7M Sell
4,416,903
-596,066
-12% -$1.7M 0.02% 416
2025
Q3
$13.2M Sell
5,012,969
-2,133,053
-30% -$4.7M 0.02% 414
2025
Q2
$8.79M Buy
7,146,022
+787,909
+12% +$859K 0.02% 459
2025
Q1
$6.99M Buy
6,358,113
+1,253,353
+25% +$1.45M 0.02% 402
2024
Q4
$4.62M Buy
5,104,760
+1,156,511
+29% +$991K 0.01% 543
2024
Q3
$3.89M Buy
3,948,249
+355,484
+10% +$342K 0.01% 564
2024
Q2
$3.23M Buy
3,592,765
+856,380
+31% +$641K 0.01% 625
2024
Q1
$3.23M Buy
2,736,385
+931,248
+52% +$1.03M 0.01% 562
2023
Q4
$1.64M Buy
1,805,137
+270,475
+18% +$200K 0.01% 725
2023
Q3
$1.28M Sell
1,534,662
-1,532,054
-50% -$1.77M 0.01% 804
2023
Q2
$3.68M Buy
3,066,716
+853,329
+39% +$1.06M 0.02% 535
2023
Q1
$2.79M Buy
2,213,387
+759,647
+52% +$1.45M 0.01% 622
2022
Q4
$3.15M Buy
+1,453,740
New +$12M 0.02% 559

Other funds holding GOSS